CRYOPORT, INC. Increase (Decrease) in Employee Related Liabilities
CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Employee Related Liabilities of -$754.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-06
- CRYOPORT, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$4.82M.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was $4.06M, a 148.68% increase year-over-year.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $2.12M, a 3.62% increase year-over-year.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $1.36M, a 210.27% increase year-over-year.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for fiscal 2025 was $1.91M, a 3.08% increase from fiscal 2024.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for fiscal 2024 was $1.85M, a 35.78% decline from fiscal 2023.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for fiscal 2023 was $2.88M.
- CRYOPORT, INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$1.57M, a 162.21% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 3 month as first filed | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 6 month as first filed | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 9 month as first filed | Increase (Decrease) in Employee Related Liabilities 12 month | Increase (Decrease) in Employee Related Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$754.00K 10-Q · filed 2026-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-08-06 | $2.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.06M 10-Q · filed 2026-05-05 | $6.18M derived: sum of 2 quarters · filed 2026-05-05 | $7.54M derived: sum of 3 quarters · filed 2026-05-05 | $4.34M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.48M derived: sum of 2 quarters · filed 2026-03-05 | $276.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.91M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.84M derived: sum of 2 quarters · filed 2026-08-06 | -$209.00K 10-Q · filed 2025-11-06 | $1.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.57M 10-Q · filed 2026-08-06 | $476.00K derived: sum of 3 quarters · filed 2026-08-06 | $914.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.63M 10-Q · filed 2026-05-05 | $3.68M derived: sum of 2 quarters · filed 2026-05-05 | $4.12M derived: sum of 3 quarters · filed 2026-05-05 | $766.00K derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.48M derived: sum of 2 quarters · filed 2026-03-05 | -$867.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.85M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.91M derived: sum of 2 quarters · filed 2025-11-06 | -$192.00K 10-Q · filed 2025-11-06 | $679.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | -$3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$630.00K 10-Q · filed 2025-08-12 | $241.00K derived: sum of 3 quarters · filed 2026-03-05 | $2.01M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $2.72M 10-Q · filed 2025-05-08 | $3.59M derived: sum of 2 quarters · filed 2026-03-05 | $5.36M derived: sum of 3 quarters · filed 2026-03-05 | $3.64M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.64M derived: sum of 2 quarters · filed 2026-03-05 | $922.00K derived: sum of 3 quarters · filed 2026-03-05 | $2.88M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $51.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.01M 10-Q · filed 2024-11-07 | $1.66M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $248.00K 10-Q · filed 2024-08-08 | -$103.00K derived: sum of 3 quarters · filed 2025-03-07 | $260.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.96M 10-Q · filed 2024-05-08 | $1.61M derived: sum of 2 quarters · filed 2025-03-07 | $1.97M derived: sum of 3 quarters · filed 2025-03-07 | -$1.75M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $12.00K derived: sum of 2 quarters · filed 2025-03-07 | -$3.71M derived: sum of 3 quarters · filed 2025-03-07 | -$1.57M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$3.36M derived: sum of 2 quarters · filed 2023-11-09 | -$1.22M 10-Q · filed 2023-11-09 | $59.00K derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.58M 10-Q · filed 2023-08-09 | -$304.00K derived: sum of 3 quarters · filed 2024-03-13 | $1.60M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $2.14M 10-Q · filed 2023-05-04 | $3.42M derived: sum of 2 quarters · filed 2024-03-13 | $5.32M derived: sum of 3 quarters · filed 2024-03-13 | $3.86M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.18M derived: sum of 2 quarters · filed 2024-03-13 | $1.72M derived: sum of 3 quarters · filed 2024-03-13 | $2.52M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $441.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.25M 10-Q · filed 2022-11-04 | $3.74M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$661.00K 10-Q · filed 2022-08-04 | $1.83M derived: sum of 3 quarters · filed 2023-02-28 | $2.53M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $804.00K 10-Q · filed 2022-05-05 | $3.30M derived: sum of 2 quarters · filed 2023-02-28 | $4.00M derived: sum of 3 quarters · filed 2023-02-28 | $3.18M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.19M derived: sum of 2 quarters · filed 2023-02-28 | $2.38M derived: sum of 3 quarters · filed 2023-02-28 | $3.14M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$117.00K derived: sum of 2 quarters · filed 2021-11-04 | $651.00K 10-Q · filed 2021-11-04 | $651.03K 10-Q · filed 2020-11-06 | $987.32K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$51.00K 10-Q · filed 2021-08-06 | -$51.53K 10-Q · filed 2020-08-10 | $285.32K derived: sum of 3 quarters · filed 2022-02-28 | $318.22K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $768.00K 10-Q · filed 2021-05-06 | $767.75K 10-Q · filed 2020-05-08 | $1.10M derived: sum of 2 quarters · filed 2022-02-28 | $1.14M derived: sum of 3 quarters · filed 2022-02-28 | $917.88K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $336.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $369.22K derived: sum of 2 quarters · filed 2022-02-28 | $149.88K derived: sum of 3 quarters · filed 2022-02-28 | $641.00K 10-K · filed 2022-02-28 | $641.24K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $32.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$186.45K derived: sum of 2 quarters · filed 2020-11-06 | $304.68K 10-Q · filed 2020-11-06 | $682.03K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$219.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $271.78K 10-Q · filed 2020-08-10 | $649.14K derived: sum of 3 quarters · filed 2020-08-10 | $631.11K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $491.12K 10-Q · filed 2020-05-08 | $868.48K derived: sum of 2 quarters · filed 2020-05-08 | $850.45K derived: sum of 3 quarters · filed 2020-05-08 | $678.84K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $377.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $359.33K derived: sum of 2 quarters · filed 2020-03-10 | $187.72K derived: sum of 3 quarters · filed 2020-03-10 | $336.74K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$18.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$189.64K derived: sum of 2 quarters · filed 2019-11-12 | -$40.62K 10-Q · filed 2019-11-12 | $256.10K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$171.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$22.59K 10-Q · filed 2019-08-09 | $274.13K derived: sum of 3 quarters · filed 2019-08-09 | $304.59K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $149.02K 10-Q · filed 2019-05-09 | $445.74K derived: sum of 2 quarters · filed 2019-05-09 | $476.21K derived: sum of 3 quarters · filed 2019-05-09 | $660.91K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $296.72K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $327.19K derived: sum of 2 quarters · filed 2019-03-13 | $511.89K derived: sum of 3 quarters · filed 2019-03-13 | $506.48K 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $30.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $215.17K derived: sum of 2 quarters · filed 2018-11-08 | $209.76K 10-Q · filed 2018-11-08 | $260.56K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $184.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $179.29K 10-Q · filed 2018-08-09 | $230.09K derived: sum of 3 quarters · filed 2018-08-09 | $221.48K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$5.41K 10-Q · filed 2018-05-03 | $45.39K derived: sum of 2 quarters · filed 2018-05-03 | $36.78K derived: sum of 3 quarters · filed 2018-05-03 | -$95.13K derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $50.80K derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08 | $42.19K derived: sum of 2 quarters · filed 2018-03-08 | -$89.72K 10-K · filed 2018-03-08 | $41.92K 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | -$8.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | -$140.52K 10-Q · filed 2016-11-14 | -$8.88K 10-Q · filed 2017-11-02 | $1.31K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-06-30 | -$131.91K 10-Q · filed 2016-08-15 | -$269.00 10-Q · filed 2017-08-09 | $9.92K derived: sum of 3 quarters · filed 2017-05-04 | -$45.69K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2016-03-31 | $131.64K 10-Q · filed 2017-05-04 | $141.83K derived: sum of 2 quarters · filed 2017-05-04 | $86.22K derived: sum of 3 quarters · filed 2017-05-04 | -$162.15K 10-KT · filed 2017-03-13 | ||||
| 2015-12-31 | $10.19K derived: 10-KT 9 month − 10-Q 6 month · filed 2017-03-13 | -$45.42K derived: sum of 2 quarters · filed 2017-03-13 | -$330.88K 10-KT · filed 2017-03-13 | -$222.80K derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-09-30 | -$55.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | -$341.07K 10-Q · filed 2016-11-14 | -$232.99K derived: sum of 3 quarters · filed 2016-11-14 | -$165.02K derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | -$285.46K 10-Q · filed 2016-08-15 | -$177.38K derived: sum of 2 quarters · filed 2016-08-15 | -$109.41K derived: sum of 3 quarters · filed 2016-08-15 | -$61.76K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $108.08K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28 | $176.05K derived: sum of 2 quarters · filed 2016-06-28 | $223.70K derived: sum of 3 quarters · filed 2016-06-28 | $271.42K 10-K · filed 2016-06-28 | ||||
| 2014-12-31 | $67.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-11 | $115.62K derived: sum of 2 quarters · filed 2016-02-11 | $163.35K 10-Q · filed 2016-02-11 | $226.20K derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-09-30 | $47.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | $95.37K 10-Q · filed 2015-11-16 | $158.22K derived: sum of 3 quarters · filed 2015-11-16 | $207.23K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $47.73K 10-Q · filed 2015-08-06 | $110.58K derived: sum of 2 quarters · filed 2015-08-06 | $159.59K derived: sum of 3 quarters · filed 2015-08-06 | $221.57K derived: sum of 4 quarters · filed 2015-08-06 | ||||
| 2014-03-31 | $62.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $111.86K derived: sum of 2 quarters · filed 2015-05-19 | $173.84K derived: sum of 3 quarters · filed 2015-05-19 | $236.86K 10-K · filed 2015-05-19 | ||||
| 2013-12-31 | $49.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $110.99K derived: sum of 2 quarters · filed 2015-02-05 | $174.01K 10-Q · filed 2015-02-05 | |||||
| 2013-09-30 | $61.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12 | $125.00K 10-Q · filed 2014-11-12 | ||||||
| 2013-06-30 | $63.01K 10-Q · filed 2014-07-31 | |||||||
| 2013-03-31 | -$18.56K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |